| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:53 UTC |
|---|
| HMDB ID | HMDB0015185 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Novobiocin |
|---|
| Description | Novobiocin is only found in individuals that have used or taken this drug. It is an antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) [PubChem]Novobiocin is an aminocoumarin. Aminocoumarins are very potent inhibitors of bacterial DNA gyrase and work by inhibiting the GyrB subunit of the enzyme involved in energy tranduction. Novobiocin as well as the other aminocoumarin antibiotics act as competitive inhibitors of the ATPase reaction catalysed by GyrB. |
|---|
| Structure | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | ChEBI | | Novobiocina | ChEBI | | Novobiocine | ChEBI | | Novobiocinum | ChEBI | | N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-b-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | Generator | | N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-β-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide | Generator | | Antibiotic pa-93 | HMDB | | Crystallinic acid | HMDB | | NOV | HMDB | | Sodium, novobiocin | HMDB | | Streptonivicin | HMDB | | Calcium, novobiocin | HMDB | | Monosodium salt novobiocin | HMDB | | Novobiocin, monosodium salt | HMDB | | Novobiocin calcium | HMDB | | Novobiocin sodium | HMDB |
|
|---|
| Chemical Formula | C31H36N2O11 |
|---|
| Average Molecular Weight | 612.6243 |
|---|
| Monoisotopic Molecular Weight | 612.231910004 |
|---|
| IUPAC Name | (3R,4S,5R,6R)-5-hydroxy-6-({4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-8-methyl-2-oxo-2H-chromen-7-yl}oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate |
|---|
| Traditional Name | novobiocin |
|---|
| CAS Registry Number | 303-81-1 |
|---|
| SMILES | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C |
|---|
| InChI Identifier | InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 |
|---|
| InChI Key | YJQPYGGHQPGBLI-KGSXXDOSSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as coumarin glycosides. These are aromatic compounds containing a carbohydrate moiety glycosidically bound to a coumarin moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Coumarins and derivatives |
|---|
| Sub Class | Coumarin glycosides |
|---|
| Direct Parent | Coumarin glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Coumarin-7-o-glycoside
- Coumarin o-glycoside
- Phenolic glycoside
- 4-hydroxycoumarin
- Hydroxycoumarin
- Hexose monosaccharide
- O-glycosyl compound
- Glycosyl compound
- Benzopyran
- 1-benzopyran
- Benzamide
- Benzoic acid or derivatives
- Benzoyl
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Pyranone
- Pyran
- Monocyclic benzene moiety
- Monosaccharide
- Oxane
- Benzenoid
- Heteroaromatic compound
- Vinylogous acid
- Carbamic acid ester
- Carboxamide group
- Secondary carboxylic acid amide
- Secondary alcohol
- Lactone
- Carbonic acid derivative
- Ether
- Dialkyl ether
- Acetal
- Organoheterocyclic compound
- Carboxylic acid derivative
- Oxacycle
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0097 g/L | Not Available | | LogP | 4.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.03 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.8762 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.83 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 69.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2753.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 160.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 181.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 146.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 87.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 601.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 550.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 313.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1038.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 551.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1638.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 366.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 421.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 174.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 234.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Novobiocin,1TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4788.5 | Semi standard non polar | 33892256 | | Novobiocin,1TMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4779.2 | Semi standard non polar | 33892256 | | Novobiocin,1TMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4768.0 | Semi standard non polar | 33892256 | | Novobiocin,1TMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4831.0 | Semi standard non polar | 33892256 | | Novobiocin,1TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4620.3 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4693.2 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4752.0 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4559.4 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4680.6 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #3 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4757.0 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #4 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4532.4 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4700.3 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4744.8 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #7 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4499.7 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4737.4 | Semi standard non polar | 33892256 | | Novobiocin,2TMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4503.7 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4643.0 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4706.0 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4506.8 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #12 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4689.7 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #13 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4510.9 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #14 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4511.6 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #2 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4698.4 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4446.9 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4695.7 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4450.0 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4696.2 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #7 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4527.4 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4708.2 | Semi standard non polar | 33892256 | | Novobiocin,3TMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4465.4 | Semi standard non polar | 33892256 | | Novobiocin,1TBDMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4976.1 | Semi standard non polar | 33892256 | | Novobiocin,1TBDMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4968.9 | Semi standard non polar | 33892256 | | Novobiocin,1TBDMS,isomer #3 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 4970.2 | Semi standard non polar | 33892256 | | Novobiocin,1TBDMS,isomer #4 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5047.5 | Semi standard non polar | 33892256 | | Novobiocin,1TBDMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4836.2 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #1 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5057.9 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #10 | CO[C@@H]1[C@@H](OC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5197.9 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #11 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4964.1 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #2 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5060.9 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #3 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5109.2 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #4 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4914.0 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #5 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5089.2 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #6 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5123.1 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #7 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O[Si](C)(C)C(C)(C)C)=C(N(C(=O)C4=CC=C(O)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4899.7 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #8 | CO[C@@H]1[C@@H](OC(=O)N[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(NC(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C | 5125.7 | Semi standard non polar | 33892256 | | Novobiocin,2TBDMS,isomer #9 | CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=CC=C3C(O)=C(N(C(=O)C4=CC=C(O[Si](C)(C)C(C)(C)C)C(CC=C(C)C)=C4)[Si](C)(C)C(C)(C)C)C(=O)OC3=C2C)OC1(C)C | 4919.9 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9501040000-ea711ce6f17080b821c2 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (1 TMS) - 70eV, Positive | splash10-000i-9531007000-845ccc25b7b9a4ba819d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_2_11) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Novobiocin GC-MS (TMS_3_8) - 70eV, Positive | Not Available | 2021-10-16 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-03di-0000009000-b1cde524a6fa9a8469fb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-03di-0000449000-4b6598caa7dcff199d3c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0230-0005904000-5fe18777e8a9abd4250a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0a59-0096200000-4ea433cdc759c03b554d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , negative-QTOF | splash10-0a4i-0091000000-912d33bd49e7c2686b5b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-03di-0141009000-46efbf9ab2bd123e3329 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-e321cd21925818d2156a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-6425ec6e8bbb44075cf4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-32fb8ff4ec7fde30b513 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000i-0900000000-004f89ab3d920e8c5936 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin LC-ESI-QTOF , positive-QTOF | splash10-000j-0933000000-cd71bb412108d603ba2d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 50V, Negative-QTOF | splash10-0a4i-0091000000-912d33bd49e7c2686b5b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Negative-QTOF | splash10-0a59-0096200000-4ea433cdc759c03b554d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-0a59-0096200000-11dbab50d0282c78d5d3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 50V, Positive-QTOF | splash10-000i-0900000000-7e8f1b6857305a58cdd6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin -1V, Positive-QTOF | splash10-000i-0900000000-fa445cda52f068430dd9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-000i-0900000000-659dbda5f820b7b4b5a9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 10V, Positive-QTOF | splash10-03di-0141009000-46efbf9ab2bd123e3329 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Novobiocin 30V, Positive-QTOF | splash10-000i-0900000000-ba6e55c3d22bd781820c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 10V, Positive-QTOF | splash10-01ot-2319062000-88f8c273adda497b18db | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 20V, Positive-QTOF | splash10-000j-1619010000-8f36ccee24f46649d2fa | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 40V, Positive-QTOF | splash10-029i-4902000000-251ff87ab1779a3c93ee | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 10V, Negative-QTOF | splash10-0006-8092031000-b1e5ad67b96535763fdf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 20V, Negative-QTOF | splash10-0006-9003030000-1010bbb42c15ce8156a5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Novobiocin 40V, Negative-QTOF | splash10-0006-9322000000-7884d3b71b2733b2e74f | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|